# A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers

> **NCT00848081** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 318 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** Tadalafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00848081
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2010-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00848081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00848081, "A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00848081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*